Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01162707 · ClinicalTrials.gov registry record · NA
Wireless, Intermittent Monitoring of Right Heart Pressures in HF
A NA study of NYHA Class III Heart Failure, sponsored by CardioMEMS.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
- 4
- Study locations
NCT01162707 is a NA study of NYHA Class III Heart Failure that has completed, run by CardioMEMS. The registered enrollment target is 17 participants. The trial reports 4 study locations across 4 states.
The verdict
NCT01162707, a NA study of NYHA Class III Heart Failure, has completed, sponsored by CardioMEMS.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
- 4
- Study locations
Study Summary
The purpose of the trial is to evaluate the wireless monitoring of pulmonary artery pressure using the CardioMEMS HF Pressure Measurement System in adult subjects with NYHA Class III Heart Failure.
Conditions Studied
Interventions
- DEVICE CardioMEMS HF Pressure Measurement System
Study Locations (4)
Georgia
- Piedmont Hospital - Atlanta
Ohio
- Ohio State University Hospital - Columbus
Oklahoma
- Oklahoma Heart Hospital - Oklahoma City
Tennessee
- St Thomas Hospital - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2006-12 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01162707
The ClinicalTrials.gov registry entry for NCT01162707 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CardioMEMS, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with NYHA Class III Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which CardioMEMS HF Pressure Measurement System is the first listed.
NCT01162707 reports 4 study locations spanning 4 distinct geographic areas - top geographies include Georgia, Ohio, Oklahoma.
Frequently Asked Questions
What is clinical trial NCT01162707 about?
NCT01162707 is a clinical study titled "Wireless, Intermittent Monitoring of Right Heart Pressures in HF". The purpose of the trial is to evaluate the wireless monitoring of pulmonary artery pressure using the CardioMEMS HF Pressure Measurement System in adult subjects with NYHA Class III Heart Failure.
What is the current status of trial NCT01162707?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2006-12. Estimated completion is 2012-09.
What conditions does trial NCT01162707 study?
This clinical trial studies the following conditions: NYHA Class III Heart Failure.
What interventions are being tested in trial NCT01162707?
The interventions under investigation include: CardioMEMS HF Pressure Measurement System (DEVICE).
Who is sponsoring clinical trial NCT01162707?
This trial is sponsored by CardioMEMS, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01162707 being conducted?
This trial has 4 study locations across Georgia, Ohio, Oklahoma, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for NYHA Class III Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.